What happened to the Blackmores (ASX:BKL) share price last earnings season?

Here we peel back the onion on what happened when Blackmores last reported earnings.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Blackmores Limited (ASX: BKL) share price has climbed just over 2% in the last month. In comparison, the S&P/ASX 200 index (ASX: XJO) is up 1.5% over the same period.

In early trading today, the Blackmores share price is up 0.56% at $78.97 apiece.

As the nutritional supplement company prepares to report its FY21 earnings on Thursday, let's take a look at what happened to the Blackmores share price last earnings season back in February.

blackmores share price

Image source: Getty Images

What did Blackmores deliver in its half year results?

Blackmores detailed a pattern of growth in its FY21 half-year results in February, including:

  • Revenue of $302.6 million that grew 4% on a constant currency basis
  • International and China revenue growth of 13% and 25% respectively
  • 10% decline in ANZ revenue to $148 million
  • Net profit after tax (NPAT) of $19.4 million, an 8% increase from the year prior
  • Fully franked interim dividend of 29 cents per share.

While Blackmores did not shed any colour on guidance expectations, it did state that revenue in H2 would be "slightly lower" than H1.

Furthermore, it announced it would hand back $2.4 million of the $10.4 million in Jobkeeper assistance provided by the government for COVID-19 relief.

How did the Blackmores share price react?

The results were well received by the market, as investors drove the Blackmores share price north in the days following the announcement.

Blackmores shares climbed around 10% in the two days after the report, peaking at $81.41 before retracing to $76.57 the week after.

Afterwards, the Blackmores share price regained momentum and again shot back up near its 52-week high, closing at $87.19 on 15 March.

One month after its FY21 half-year results, Blackmores shares closed at $82.92, a 12% climb, despite no other market-sensitive information during this time.

Considering how its earnings growth was a positive to the Blackmores share price in February, investors will no doubt hope for a similar performance this time around.

This is especially true when factoring the recent run-up on the charts the company's shares have exhibited since May.

At the current Blackmores share price, the company has a market capitalisation of $1.5 billion.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Blackmores Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Two scientists analysing results on a computer screen.
Healthcare Shares

3 ASX healthcare shares to buy with 25% to 100% upside as sector rebound races higher

After slumping to a 9-year low on 3 June, healthcare shares have rallied by an extraordinary 42%.

Read more »

A female scientist in a laboratory setting using a tablet to review data, with a male scientist working in the background.
Healthcare Shares

Are CSL shares still cheap after almost doubling since June?

The healthcare giant is no longer dirt cheap, but let's find out if the current valuation leaves room for long-term…

Read more »

Buy the dip written on a yellow sign.
Broker Notes

Down 43%! 4 reasons to buy the BIG dip in Pro Medicus shares today

A leading expert believes Pro Medicus shares are well-place to rebound.

Read more »

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

CSL led the ASX healthcare shares rebound. Can it continue?

The rebound of healthcare stocks looks promising, but proving the recovery is real remains.

Read more »

Three guys in shirts and ties give the thumbs down.
Healthcare Shares

Ingenia Communities Group rejects takeover offer, backs growth strategy

Ingenia Communities Group has rejected a takeover offer from Warburg Pincus, reaffirming its strategy and Peet acquisition plans.

Read more »

a man in a shirt and tie holds his chin in thoughtful contemplation and looks skywards as if thinking about something while a graphic of a road with many ups and downs unfurls behind him.
Healthcare Shares

CSL shares are up 94% from their low. What are brokers forecasting next?

Can CSL’s improving fundamentals justify the optimism now priced into shares?

Read more »

Woman with $50 notes in her hand thinking, symbolising dividends.
Dividend Investing

Looking to bank the upcoming CSL dividend? You better hurry!

Not only have CSL shares surged 91% since June, but the final dividend payout is still up for grabs. Though…

Read more »

a group of surgeons in full surgery dress including masks, gloves and head coverings stands together with arms folded and smiling eyes as if happy with the outcome of their efforts.
Healthcare Shares

Top 3 ASX healthcare shares to buy after a brutal year

Three very different ways to back healthcare.

Read more »